Search criteria | ||||
Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study | ||||
Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V. | ||||
"Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland." | ||||
Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582 |
||||
, Article | ||||
, Denmark, Finland, Netherlands , Sweden, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Oncology | 2022 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
An exploratory assessment of the applicability of direct-to-consumer genetic testing to translational research in Japan | ||||
Masahiro Inoue 1, Shota Arichi 1, Tsuyoshi Hachiya 1, Anna Ohtera 2, Seok-Won Kim 2, Eric Yu 2, Masatoshi Nishimura 3, Kazuhito Shiosakai 3, Takeshi Ohira 3 (rwesheorj 2) | ||||
1) HealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan 2) Real World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan 3) Daiichi Sankyo Co. Ltd, Tokyo, Japan | ||||
BMC Research Notes |
||||
, Article | ||||
, Japan | ||||
Abstract: https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-021-05696-4 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2021 | English | , Methodology, Patient questionnaire, Real World Evidence, Survey research | |
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK | ||||
Orla M Doyle 1 2, Roald van der Laan 3 2, Marko Obradovic 4 2, Peter McMahon 5, Flora Daniels 6, Ashley Pitcher 7, Michael R Loebinger 8 | ||||
Predictive Analytics, Real World Analytical Solutions, IQVIA, London, UK. 2These authors contributed equally. 3Insmed Utrecht, Utrecht, The Netherlands. 4Insmed Utrecht, Utrecht, The Netherlands marko.obradovic@insmed.com. 5Real-World Insights, IQVIA, London, UK. 6Real-World Insights, IQVIA, Basel, Switzerland. 7Real-World Insights, IQVIA, Copenhagen, Denmark. 8Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London, UK. | ||||
PMID: 32430411 DOI: 10.1183/13993003.00045-2020 |
||||
, Article | ||||
, Switzerland, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32430411/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Pain | 2021 | English | , Population Based Study, Real World Evidence, Retrospective database analysis | |
Validation of an ICD-10-based algorithm to identify stillbirth in the Sentinel System | ||||
Andrade SE, Shinde M, Moore Simas TA, Bird ST, Bohn J, Haynes K, Taylor LG, Lauring JR, Longley E, McMahill-Walraven CN, Trinacty CM, Saphirak C, Delude C, DeLuccia S, Zhang T, Cole DV, DiNunzio N, Gertz A, Fazio-Eynullayeva E, Stojanovic D | ||||
"1The Meyers Primary Care Institute, a joint endeavor of the University of Massachusetts Medical School, Reliant Medical Group, and Fallon Health, University of Massachusetts Medical School, Worcester, Massachusetts, USA. 2Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA. 3Department of Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care, Worcester, Massachusetts, USA. 4Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. / L Taylor - IQVIA - RWS 5Department of Scientific Affairs, HealthCore, Inc., Wilmington, Delaware, USA. 6Community Health Care Family Medicine Residency, Tacoma, Washington, USA. 7CVS Health Clinical Trial Services, Part of the CVS Health Family of Companies, Blue Bell, Pennsylvania, USA. 8Kaiser Permanente Center for Integrated Health Care Research Hawaii and Office of Public Health Studies, University of Hawai'i Manoa, Honolulu, Hawaii, USA." | ||||
"Pharmacoepidemiol Drug Saf. 2021 Sep;30(9):1175-1183. doi: 10.1002/pds.5300. Epub 2021 Jun 11. PMID: 34089206" |
||||
, Article | ||||
, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34089206/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Womens Health | 2021 | English | , Epidemiological study, Retrospective database analysis | |
Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety. | ||||
Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-Gabarró 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13 | ||||
1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium. | ||||
Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13. |
||||
, Article | ||||
, Belgium, Germany, UK, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33146896/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods | 2021 | English | , Patient questionnaire, Review | |
Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee | ||||
Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1 | ||||
1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom | ||||
First published: 18 January 2020 https://doi.org/10.1002/cpt.1775 |
||||
, Abstract, Article | ||||
, France, Germany, UK | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1775 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Health policy | 2020 | English | , Retrospective database analysis | |
IQVIA hospital information system DATA secondary use for outcome identification to assess the validity of definitions | ||||
Masaya H 1, Kenji Hamada 1, Masafumi Okada 1, Dilinuer Ainiwaer 1, Masaaki I 1, Takeshi Akiyama 1 (rwesheorj 1) | ||||
1) IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
ISPOR Asia Pacific |
||||
, Abstract, Conference, Presentation | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104325 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , De-identification / anonymisation | |
Retrospective study for comorbidities in ACTIVE population using Japanese health insurance claims database | ||||
Seok-Won Kim 1, Ayumi Morishita 1, Takeshi Akiyama 1 (rwesheorj 1) | ||||
1) Real World Evidence Solutions, IQVIA Solutions Japan K.K. | ||||
ISPOR Asia Pacific 2020 Conference |
||||
, Abstract | ||||
, Japan | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/asia2020-3264/104345 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , Database Study | |
Development and validation of patient-level prediction models for adverse outcomes following total knee arthroplasty | ||||
Ross D. Williams, Jenna M. Reps, Anthony G. Sena, Edward Burn, Ying He, Daniel R. Morales, David Culliford, Dahai Yu, Victoria Y. Strauss, Talita Duarte-Salles, Albert Prats-Uribe, Antonella Delmestri, James Weaver, William Sproviero, Danielle Robinson, Henry Morgan Stewart, Belay Birlie, Rafael Pinedo-Villanueva, Spyros Kolovos, Luis H. John, Ruth E. Costello, Michel van Speybroeck, Caroline O’Leary, Evan Minty, Thomas Falconer, Alison Callahan, Stephen Pfohl, Theresa Burkard, Jennifer Lane, Peter R. Rijnbeek, Patrick B. Ryan, Daniel Prieto-Alhambra | ||||
1Erasmus University Medical Centre, Rotterdam 2Janssen Research and Development, Raritan, NJ, USA 3NDORMS, University of Oxford, Oxford, UK 4University of Dundee, UK 5NIHR Applied Research Collaboration Wessex, University of Southampton, UK 6Keele University, Keele, UK 7Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain 8Department of Psychiatry, University of Oxford, Oxford, UK 9IQVIA, London, UK 10Centre for Epidemiology Versus Arthritis, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK 11Janssen Pharmaceutica, Beerse, Belgium 12O’Brien Institute of Public Health, Faculty of Medicine, University of Calgary, Alberta, Canada 13Department of Biomedical Informatics, Columbia University Medical Center 14Center for Biomedical Informatics Research, School of Medicine, Stanford University, Stanford, California, USA 15University of Basel, Switzerland | ||||
doi: https://doi.org/10.1101/2020.12.14.20240994 |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://www.medrxiv.org/content/10.1101/2020.12.14.20240994v1 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , clinical setting: Secondary care, Database Study, direct to patient research, Methodology, Observational study | |
Prescribing Pathways to Triple Therapy: A Retrospective Observational Study of Adults with Chronic Obstructive Pulmonary Disease in the UK | ||||
Jennifer K Quint 1, Alessandra Venerus 2, Caroline O'Leary 2, Melissa Myland 2, Ulf Holmgren 3, Precil Varghese 4, Claudia Cabrera 3 5 | ||||
1Imperial College London, London, UK. 2IQVIA, London, UK. 3Real World Science and Digital, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden. 4Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA. 5Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. | ||||
PMID: 33324049 PMCID: PMC7733404 DOI: 10.2147/COPD.S278101 |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33324049/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , Observational study, Retrospective database analysis | |
Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study | ||||
Mounika Parimi 1, Henrik Svedsater 2, Quratul Ann 1, Mugdha Gokhale 3, Christen M Gray 1, David Hinds 3, Mark Nixon 1, Naomi Boxall 1 | ||||
1Real World Solutions, IQVIA, London, UK. 2Value Evidence and Outcomes, GlaxoSmithKline Plc., Brentford, Middlesex, UK. henrik.x.svedsater@gsk.com. 3Epidemiology, GlaxoSmithKline Plc., Collegeville, PA, USA. | ||||
PMID: 32361850 PMCID: PMC7467428 DOI: 10.1007/s12325-020-01344-8 |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32361850/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2020 | English | , Real World Data, Retrospective database analysis | |
Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review. | ||||
Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2 | ||||
1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA | ||||
Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224 |
||||
, Article | ||||
, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4711 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Multiple imputation for systematically missing confounders within a distributed data drug safety network: a simulation study and real-world example | ||||
Secrest MH, Platt RW, Reynier P, Dormuth CR, Benedetti A, and Filion KB | ||||
IQVIA, Cambridge, MA | ||||
Pharmacoepidemiology & Drug Safety (In press) |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
The Establishment and Refinement of the National Basketball Association Player Injury and Illness Database | ||||
Mack CD, Meisel P, Herzog MM, Callahan L, Oakkar EE, Walden T, Sharpe J, Dreyer NA, DiFiori J | ||||
IQVIA Real-World & Analytics Solutions, Research Triangle Park, Durham, NC. University of North Carolina at Chapel Hill. National Basketball Association, New York, NY. Hospital for Special Surgery, New York, NY. National Basketball Athletic Trainers Association, Charlotte, NC. | ||||
ncbi.nlm.nih.gov/pubmed/31074633 |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31074633 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Injuries, Orthopedics | 2019 | English | , Epidemiological study, Observational study, Retrospective database analysis | |
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis | ||||
Damián GarcÃÂa-Olmo 1, Gert Van Assche 2, Ignacio Tagarro 3, Mary Carmen Diez 4, Marie Paule Richard 4, Javaria Mona Khalid 5, Marc van Dijk 5, Dimitri Bennett 6 7, Suvi R K Hokkanen 8, Julián Panés 9 | ||||
1Hospital Universitario Fundación Jiménez DÃÂaz, Av de los Reyes Católicos, 2, 28040, Madrid, Spain. damian.garcia@uam.es. 2Department of Gastroenterology and Hepatology, University Hospitals Leuven and Katholic University Leuven, Leuven, Belgium. 3Takeda Spain, Madrid, Spain. 4TiGenix (Takeda Group), Madrid, Spain. 5Takeda Development Centre Europe, London, UK. 6Department of Pharmacoepidemiology, Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. 7Center for Clinical Epidemiology and Biostatistics, Adjunct, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 8IQVIA, London, UK. 9Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain. | ||||
Adv Ther . 2019 Dec;36(12):3503-3518. doi: 10.1007/s12325-019-01117-y. Epub 2019 Oct 26. |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31656013/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Prevalence of anal fistula in the United Kingdom | ||||
Suvi Rk Hokkanen 1, Naomi Boxall 1, Javaria Mona Khalid 2, Dimitri Bennett 3, Haridarshan Patel 4 | ||||
1Real World Evidence Solutions, IQVIA, London N19JY, United Kingdom. 2Evidence and Value Generation, Global Medical Affairs, Takeda Pharmaceuticals International Inc., London WC2B 4AE, United Kingdom. 3Department of Epidemiology, Takeda Pharmaceuticals International Inc., Cambridge, MA 02139, United States; Adjunct, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States. 4Evidence and Value Generation, Global Medical Affairs, Takeda Pharmaceuticals International Inc., Deerfield, IL 6001, United States. hari.patel@takeda.com. | ||||
World J Clin Cases . 2019 Jul 26;7(14):1795-1804. doi: 10.12998/wjcc.v7.i14.1795. |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31417925/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Database Study, Retrospective database analysis | |
Seizure frequency, healthcare resource utilisation and mortality in childhood epilepsy: a retrospective cohort study using the THIN database | ||||
Melissa Myland 1, Brian Buysse 1, Wan Tsong 2, G Sarah Power 1, Douglas Nordli 3, Richard F M Chin 4 5 | ||||
1IQVIA, London, UK. 2Eisai Inc, Woodcliff Lake, UK. 3Children's Hospital of Los Angeles, Los Angeles, USA. 4Muir Maxwell Epilepsy Centre, Edinburgh, UK. 5Paediatric Neurosciences, Royal Hospital for Sick Children, Edinburgh, UK. | ||||
Arch Dis Child . 2019 Nov;104(11):1070-1076. doi: 10.1136/archdischild-2019-316910. Epub 2019 Jul 4. |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31272968/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Database Study, Retrospective database analysis | |
Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN) | ||||
Edward B Jude 1, Caroline O'Leary 2, Melissa Myland 2, Mark Nixon 2, Nick Gooch 3, Alka Shaunik 4, Elisheva Lew 5 | ||||
1Diabetes Centre Tameside General Hospital Ashton-under-Lyne UK. 2IQVIA London UK. 3Sanofi Guildford UK. 4Sanofi Bridgewater NJ USA. 5Sanofi Chilly-Mazarin France. | ||||
Endocrinol Diabetes Metab . 2019 Sep 29;3(1):e00094. doi: 10.1002/edm2.94. eCollection 2020 Jan. |
||||
, Article | ||||
, UK | ||||
Abstract: https://www.imsrwebibliography.com/Admin/addbibliography.php | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2019 | English | , Database Study, Retrospective database analysis | |
Basic characteristics and representativeness of the German Disease Analyzer Database | ||||
Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. | ||||
Institute of Biometrics, Epidemiology, German Diabetes Center, Düsseldorf, Real World Insights, IQVIA, Frankfurt, Germany | ||||
Int J Clin Pharmacol Ther. 2018 Aug 31. doi: 10.5414/CP203320
. |
||||
, Article | ||||
, Germany | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Basic+characteristics+and+representativeness+of+the+German+Disease+Analyzer+Database%E2%80%A9. | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2018 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Retrospective cohort analysis | |
Database Analysis of Venous Thromboembolism Treatment Patterns in Inpatients vs Outpatient Settings | ||||
Woodcroft KJ, Phillips S, Maranzano G, Caberwal H | ||||
Woodcroft KJ: Henry Ford Health System; Phillips S: IQVIA; Maranzano G: Boehringer Ingelheim Pharmaceuticals; Caberwal H: Boehringer Ingelheim Pharmaceuticals | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe | ||||
Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA | ||||
Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Denmark, Finland, Germany, Norway, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review | |
Developing a Multiphase Claims-Based Algorithm for Non-Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Measuring Colorectal Cancer Screening Rates in a US Administrative Claims Database | ||||
Carrington CM, Johnson KE, Fedwa S, Wiatrek S, Lombardo J, Pirolli M, Oliveria SA | ||||
Carrington CM: IQVIA; Johnson KE: IMPAQ International; Fedwa S: American Cancer Society, Atlanta GA; Wiatrek S: American Cancer Society, Austin TX; Lombardo J: American Cancer Society Philadelphia PA; Pirolli M: American Cancer Society Philadelphia PA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Identification of Incident Pancreatic Cancer in Administrative Health Data: A Validation Study by the Canadian Network for Observational Drug Effect Studies | ||||
Wu JW, Axzoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion K | ||||
Wu JW: Analysis Group; Secrest MH: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Canada | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes, Oncology | 2018 | English | , Database Study, Retrospective cohort analysis, Retrospective database analysis | |
Developing a Multiphase Claims-Based Algorithm for Live Pregnancy Outcomes Research | ||||
Secrest MH, Phillips S, Shen SW, Woodcroft WJ, Oliveria SA, Simon TA | ||||
Secrest MH: IQVIA; Phillips S: IQVIA; Shen SW: Bristol-Myers Squibb; Woodcroft WJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol-Myers Squibb | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods, Pregnancy | 2018 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Dermatology, Drug Utlization Study, Urology | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Linking Electronic Health Data in Pharmacoepidemiology: Appropriateness and feasibility | ||||
Donna R. Rivera, PharmD. MSc. 1, Mugdha N. Gokhale, PhD., MS. 2, Matthew W. Reynolds, PhD3, Elizabeth B. Andrews, PhD., MPH 4, Danielle S. Chun 5, Kevin Haynes PharmD. MSc., PharmD., MSCE. 6, Michelle Jonsson Funk, PhD 5, Kristine E. Lynch 7, Jennifer L. Lund, PhD. 5, Helen Strongman, MSc. 8, Harshvinder Bhullar, MSc. 9 Sudha R. Raman, PhD 10 | ||||
National Cancer Institute, National Institutes of Health, Rockville, MD. 2 GlaxoSmithKline, Philadelphia, PA. 3 Evidera, Bethesda, MD. 4 RTI International, RTP, NC. 5 UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 6 Healthcore, Inc. Philadelphia, PA. 7 VINCI, Salt Lake City, UT. 8 London School of Hygiene and Tropical Medicine, London, UK 9 IQVIA, London, UK. 10 Department of Population Health Sciences, Duke University, Durham, NC. | ||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2018 | English | , Retrospective database analysis | |
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project | ||||
Rito Bergemann, James Allsopp, Harvey Jenner, Flora Ashley Daniels, Edmund Drage, Yevgeniy Samyshkin, Claude Schmitt, Steven Wood, David G. Kiely, Allan Lawrie | ||||
"1GlaxoSmithKline, Brentford, Middlesex, UK 2Current affiliation: Evalueserve Life Sciences Healthcare, London, UK 3Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK 4IQVIA, London, UK 5Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 6National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK 7INSIGNEO, University of Sheffield, Sheffield, UK" | ||||
Pulm Circ. 2018 Oct-Dec;8(4):2045894018798613. doi: 10.1177/2045894018798613. |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease | 2018 | English | , Retrospective database analysis | |
Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension | ||||
"David G. Kiely MD, Allan Lawrie, Orla Doyle PhD, Valentina Salvatelli PhD, Flora Ashley Daniels PhD, Edmund Drage, Harvey Jenner, John Rigg, Claude Schmitt, Yevgeniy Samyshkin, Rito Bergemann " | ||||
1Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK; 2Real-World & Analytical Solutions, IQVIA, London, UK; 3GSK, Brentford, Middlesex, UK; 4Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK; 5INSIGNEO, University of Sheffield, Sheffield, UK; 6Evalueserve UK Ltd, London, UK. 1 Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK. 2 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. 3 INSIGNEO, University of Sheffield, Sheffield, UK. 4 Real-World & Analytical Solutions, IQVIA, London, UK. 5 GlaxoSmithKline, Brentford, Middlesex, UK. | ||||
European Respiratory Journal 2018 52: Suppl. 62, PA3082. |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease | 2018 | English | , Retrospective database analysis | |
Estimation of Missed Statin Prescription Use in an Administrative Claims Dataset | ||||
Wade R., Jeetvan P., Hill J., De A., Harrison D. | ||||
QuintilesIMS Health, Amgen | ||||
Journal of Managed Care & Specialty Pharmacy Vol.23, No. 9, 936-944 |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology | 2017 | English | , Compliance, Methodology, Retrospective database analysis | |
CONVERSION OF A FRENCH ELECTRONIC MEDICAL RECORD (EMR) DATABASE INTO THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL. | ||||
Schwalm MS 1, Raoul T 1 ,Chu D 2 , Shah U 3, Potdar M 4, Van Zandt M 5,Coffin G 1, Jouaville SL1 | ||||
1 QuintilesIMS, 90-92 Route de la Reine 92773 Boulogne-Billancourt, France 2 QuintilesIMS, One IMS Drive Plymouth Meeting, PA 19462 USA 3 QuintilesIMS, 100 IMS Drive Parsippany, NJ 07054 USA 4 QuintilesIMS, 291 King George Road, Warren, NJ 07059Warren, NJ USA 5 QuintilesIMS, 425 Market, San Francisco, CA 94105 San Francisco, CA USA | ||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology | 2017 | English | , Clinical setting: Primary care, Methodology | |
Creating a Rare Disease Cohort Using Ambulatory Electronic Medical Record (AEMR) Data: Duchenne Muscular Dystrophy (DMD) | ||||
Anderson A1, Casso D1, Susan A. Oliveria SA 1, Douglas Kou T 2 | ||||
1 QuintilesIMS ,2 BMS | ||||
33rd International Conference on Pharmacoepidemiology & Thereputic Risk Management; August, 28, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Musculoskeletal disease, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Can Valid Cases of Schizophrenia Be Identified in Administrative Claims Data? | ||||
Syd Phillips, Matthew Sidovar, Deb Casso, Jeremiah J. Trudeau, Kimberley J. Woodcroft, Susan A. Oliveria | ||||
P, DC, and SAO QuintilesIMS. MT, JT Boehringer Pharmaceuticals (BI | ||||
Conference: 33rd International Conference of Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Mental health, Patient Registries & Real-World Study Methods | 2017 | English | , Retrospective cohort analysis | |
Development of a Multi-Phase Claims-Based Algorithm for Pregnancy Research | ||||
Syd Phillips, Karin Johnson, Sophie W. Shen, Kimberley J. Woodcroft, Susan A. Oliveria, Teresa A. Simon | ||||
IQVIA, Epidemiology and Drug Safety, Seattle, WA; (2) Bristol-Myers Squibb, Global Pharmacovigilance and Epidemiology, Hopewell, NJ; (3) Henry Ford Health System, Department of Public Health Sciences, Detroit, MI; IQVIA, Epidemiology and Drug Safety, New York, NY | ||||
33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management. August 26-30, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2017 | English | , Retrospective database analysis | |
Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs | ||||
Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL & Lo Re V 3rd | ||||
Perelman School of Medicine, University of Pennsylvania | ||||
Pharmacoepidemiology and Drug Safety |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes | 2017 | English | , Retrospective database analysis | |
Estimating the Proportion of Patients Diagnosed with Allergic Rhinitis, at Risk of Developing Asthma | ||||
Romano, M, C.M. Burton, A Domdey, P.D. Radford, M.H. Dungarwalla, and N.S. Boxall | ||||
ALK Abello, IQVIA RWI UK&I | ||||
Value in Health |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://doi.org/10.1016/j.jval.2017.08.1463 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Respiratory disease | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Estimating the Proportion of Patients Diagnosed with Allergic Rhinitis, at Risk of Developing Asthma | ||||
Burton, C.M., M Romano, A Domdey, P Radford, M.H. Dungarwalla, and N Boxall | ||||
ALK Abello, IQVIA RWI UK&I | ||||
Annals of Allergy, Asthma and Immunology |
||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Respiratory disease | 2017 | English | , Epidemiological study, Retrospective cohort analysis | |
Developing a Multi-Phase Claims-Based Algorithm to Facilitate the Study of Drug Exposure During Pregnancy | ||||
Phillips S, Johnson KJ, Shen SW, Woodcroft KJ, Oliveria SA, Simon TA | ||||
Phillips S: IQVIA; Johnson KJ: IQVIA (formerly); Shen SW: Bristol-Meyers Squibb; Woodcroft KJ: Henry Ford Health System; Oliveria SA: IQVIA; Simon TA: Bristol Meyers Squibb | ||||
American College of Rheumatology Annual Meeting, 3-8 November 2017 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Patient Registries & Real-World Study Methods, Pregnancy | 2017 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity | ||||
Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB | ||||
Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company | ||||
The Academy of Managed Care Pharmacy® NEXUS; Dallas, TX |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Dermatology, Drug Utlization Study | 2017 | English | , Database Study, Epidemiological study, Retrospective database analysis | |
"Linking individual-level data on diagnoses and dispensing for research on antibiotic use: evaluation of a novel data source from English secondary care " | ||||
Rockenschaub P, Ansell D, Shallcross L | ||||
Lead author and Ansell: IQVIA Shallcross: UCL | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2017 | English | , Retrospective database analysis | |
Using Certification to Promote Uptake of Real-World Evidence by Payers | ||||
Jodi B. Segal, Joel D. Kallich, Emma R. Oppenheim, Louis P. Garrison Jr., Sheikh Usman Iqbal, Marla Kessler, G. Caleb Alexander | ||||
1Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 2Principal, Big Health Data, Falmouth, Maine. 3Master’s Student, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. 4Professor of Pharmaceutical Outcomes Research and Policy, School of Pharmacy, University of Washington, Seattle. 5Senior Medical Affairs Leader−Neuroscience, Global Medical Affairs, AstraZeneca, Cambridge, Massachusetts. 6Vice President, Global Services and Real-World Evidence Solutions, IMS Health, Plymouth Meeting, Pennsylvania. 7Co-director, Center for Drug Safety and Effectiveness, Johns Hopkins University, and Associate Professor of Medicine and Epidemiology, Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine/Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. | ||||
J Manag Care Spec Pharm, 2016 Mar;22(3):191-196. |
||||
, Article | ||||
, USA | ||||
Abstract: http://dx.doi.org/10.18553/jmcp.2016.22.3.191 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health policy | 2016 | English | , Review | |
Evidence generation from healthcare databases: recommendations for managing change. | ||||
Bourke A1, Bate A2, Sauer BC3, Brown JS4, Hall GC5. | ||||
1IMS Health, London, UK. 2Pfizer, Tadworth, UK. 3University of Utah School of Medicine, Salt Lake City, UT, USA. 4Harvard Medical School, Boston, MA, USA. 5Grimsdyke House, London, UK. | ||||
Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):749-54. |
||||
, Article | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/27183900 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | English | , Review | |
Extracting dosage per day from free-text medication prescriptions | ||||
Törnblom M, Bergman G, Jørgensen L, Fackle-Fornius E, Rosenlund M. | ||||
ISPOR 19th annual European Congress, Vienna 2016 |
||||
, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | English | , Real World Data | |
Validité et limites de la base de données Longitudinal Patient Database France pour les études pharmacoépidémiologiques et pharmacoéconomiquesv | ||||
Sophie L. Jouaville, Hakima Miotti, Gabriel Coffin, Bruno Sarfati, Adeline Meilhoc | ||||
QuintilesIMS, Boulogne-Billancourt, France | ||||
Rev Epidemiol Sante Publique, 2016 ; 64 (5) : s280-S281 |
||||
, Abstract | ||||
, France | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0398762016302395 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | French | , Retrospective database analysis | |
Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use? | ||||
Cea Soriano L, Soriano-Gabarró M, GarcÃÂa RodrÃÂguez LA | ||||
Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Global Epidemiology, Bayer Pharma AG | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | English | , Retrospective database analysis | |
Validity of ankylosing spondylitis diagnoses in The Health Improvement Network | ||||
Dubreuil M, Peloquin C, Zhang Y, Choi HK, Inman RD, Neogi T | ||||
Boston University School of Medicine, Section of Rheumatology; VA Boston Healthcare System; Massachusetts General Hospital, Section of Rheumatology; University of Toronto, Toronto Western Hospital | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Rheumatology | 2016 | English | , Retrospective database analysis | |
Dynamic Real World Data Platform Integrating Automated Claims and Registry Data for Pharmacoepidemiologic Studies | ||||
Syd Phillips, Andre B. Araujo, Chrissa Proctor, William N. Malatestinic, Cynthia J. Larmore, Leslie R. Harrold, George W. Reed, Deb Casso, Karin Johnson, Jeremy Stamer, Susan A. Oliveria | ||||
S. Phillips, C. Proctor, D. Casso, J. Stamer, and S.A. Oliveria are employees of QuintilesIMS (formerly IMS Health) KJ was an employee of QuintilesIMS at the time of the study. A. B. Araujo, W. N. Malatestinic, and C. J. Larmore are employees and stock owners of Eli Lilly and Company. | ||||
International Conference on Pharmacoepidemiology and Therapeutic Risk Management. August 25-28; Dublin, Ireland |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2016 | English | , Review | |
Drug safety assessment using Dubai Real World Claims Database (DRWD) | ||||
Mahagaonkar SB | ||||
IMS Health, Dubai, UAE | ||||
Joint International Conference and Expo on Industrial Pharmacy & 5th Global Pharmacovigilance Summit April 28-29, 2016 Dubai, UAE |
||||
, Abstract | ||||
, Dubai | ||||
Abstract: https://www.omicsonline.org/proceedings/drug-safety-assessment-using-dubai-real-world-claims-database-drwd-43060.html | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety | 2016 | English | , Retrospective database analysis | |
Comparative Assessment of US Healthcare Databases and Linkage Capabilities for Pharmacoepidemiology Studies. | ||||
Deborah Casso, Karin Johnson, Syd Phillips, Amanda Anderson and Susan A Oliveria. | ||||
IMS Health, Plymouth Meeting, PA, United States | ||||
International Conference on Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | English | ||
Comparative Assessment of US Healthcare Databases and Linkage Capabilities for Pharmacoepidemiology Studies | ||||
Casso D, Johnson K, Phillips S, Anderson A, Oliveria SA. | ||||
Casso D: IQVIA; Johnson K: IQVIA (formerly), Phillips S: IQVIA; Anderson A: IQVIA; Oliveria SA: IQVIA | ||||
2016 International Conference on Pharmacoepidemiology and Therapeutic Risk Management |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Patient Registries & Real-World Study Methods | 2016 | English | , Database Study, Review | |
Validity and limitations of the Longitudinal Patient Database France for use in pharmacoepidemiological and pharmacoeconomics studies | ||||
Jouaville SL, Miotti H, Coffin G, Sarfati B, Meilhoc A | ||||
IMS HEALTH Information Solutions France, Boulogne-Billancourt, FRANCE | ||||
ISPOR 20th Annual International Meeting Philadelphia, PA, USA May, 201 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2015 | English | , Longitudinal study | |
ASSESSMENT OF A FRENCH ENDOCRINOLOGIST ELECTRONIC MEDICAL RECORD DATABASE FOR USE IN OBSERVATIONAL STUDIES | ||||
Hellard C, Jouaville SL, Pilet S, Meihoc A | ||||
Cededim Strategic Data, Boulogne-Billancourt, France | ||||
ISPOR 20th Annual International Meeting Philadelphia, PA, USA May, 2015 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes | 2015 | English | , Retrospective database analysis | |
Improving Utility of Electronic Health Data for Clinical Research: The Need for Harmonization | ||||
Leavy M, Barboza M, Rodriguez E, Rosenblum S, Green L. | ||||
Quintiles Real-World and Late Phase Research | ||||
Pharmacoepidemiol Drug Saf 2015; 24(S1):359. |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2015 | English | , Review, RWLPR (Real-World Late Phase Research-quintiles | |
Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology. | ||||
pharmacoepidemiology. Richter H1, Dombrowski S1, Hamer H2, Hadji P3, Kostev K4. | ||||
1IMS Health, Real World Evidence Solutions, Frankfurt, Germany. 2Department of Neurology, Epilepsy Center, University of Erlangen, Germany. 3Department of Women's Health, North West Hospital, Frankfurt, Germany. 4Fresenius University of Applied Sciences, Idstein, Germany. | ||||
Ger Med Sci. 2015; 13: Doc14. |
||||
, Review | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2015 | English | , Retrospective database analysis | |
Évaluation d’une base de données issue des dossiers médicaux informatisés d’un panel d’endocrinologues français | ||||
Christine Hellard, Sophie L. Jouaville, Simon Pilet, Adeline Meilhoc | ||||
QuintilesIMS, Boulogne-Billancourt, France | ||||
Rev Epidemiol Sante Publique, 2016 ; 64 (5) : S280-S281 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes | 2015 | French | , Retrospective database analysis | |
An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR) | ||||
de Lusignan S, Liaw ST, Dedman D, Khunti K, Sadek K, Jones S | ||||
University of Surrey, Guildford; University of New South Wales; Clinical Practice Research Datalink, London; University of Leicester, Leicester | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes | 2015 | English | , Retrospective database analysis | |
Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database. | ||||
Mamtani R, Haynes K, Boursi B, Scott F, Goldberg DS, Keefe SM, Vaughn DJ, Malkowicz SB & Lewis JD | ||||
University of Pennsylvania Abramson Cancer Center | ||||
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):303-7. doi: 10.1158/1055-9965.EPI-14-0677. Epub 2014 Nov 11 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294969/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology | 2014 | English | , Retrospective database analysis | |
Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases? | ||||
Gini R1, Schuemie MJ2, Francesconi P3, Lapi F4, Cricelli I5, Pasqua A5, Gallina P6, Donato D6, Brugaletta S7, Donatini A8, Marini A9, Cricelli C4, Damiani G10, Bellentani M11, van der Lei J2, Sturkenboom MC2, Klazinga NS12. | ||||
1Agenzia regionale di sanitàdella Toscana, Florence, Italy; Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands. 2Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.3Agenzia regionale di sanitàdella Toscana, Florence, Italy. 4Societàitaliana di medicina generale, Florence, Italy.5Genomedics, Florence, Italy.6UnitàLocale Socio Sanitaria Padova, Padua, Italy.7Azienda Sanitaria Provinciale Ragusa, Ragusa, Italy.8Assessorato Politiche per la Salute, Bologna, Italy.9Zona Territoriale Senigallia, Senigallia, Italy.10UniversitàCattolica del Sacro Cuore, Rome, Italy.11Agenzia Nazionale per il Servizi Sanitari Regionali, Rome, Italy.12Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands | ||||
PLoS One. 2014 May 9;9(5):e95419 |
||||
, Abstract | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Public Health | 2014 | French | , Retrospective database analysis | |
The moral from Sorrell: educate, don’t legislate | ||||
Gooch GR, Rohack JJ, Finley M | ||||
Texas Wesleyan School of Law, USA | ||||
Health Matrix Clevel 2013;23(1):237-277. |
||||
, Article | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=The+moral+from+Sorrell%3A+educate%2C+don%27t+legislate. | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2013 | English | , Public Health | |
ASSESSMENT OF A CANADIAN PRIMARY CARE ELECTRONIC MEDICAL RECORD DATABASE FOR USE IN OBSERVATIONAL STUDIES | ||||
Frise S1, Reidel K2, Tarride JE1, Corner N2, Dziarmaga A1 | ||||
1 AstraZeneca Canada Inc., Mississauga, ON, Canada, 2 IMS Brogan Canada, Kirkland, QC, Canada | ||||
ISPOR 16th Annual European Congress, Dublin,November, 2013 Value in Health, 2013, 16(7): A582 |
||||
, Poster | ||||
, Canada | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03503-1/abstract | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2013 | English | , Retrospective database analysis | |
Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates | ||||
Blak BT, Thompson M, Dattani H & Bourke A | ||||
Cegedim Strategic Data Medical Research Ltd, London, UK. | ||||
Inform Prim Care . 2011;19(4):251-5. doi: 10.14236/jhi.v19i4.820. |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/22828580/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Health economics | 2011 | English | , Database Study | |
Health and disease management - Italian chapter. | ||||
Heiman F 1, Katz P 1, Riccardi S 1 | ||||
1 BKL Consulting srl | ||||
ISPOR Health & Disease Management SIG Forum. |
||||
, Presentation | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2009 | English | , Methodology | |
Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. | ||||
Becher H1, Kostev K2, Schröder-Bernhardi D. | ||||
1Ruprecht-Karls-University, Heidelberg, Germany; 2, IMS Health Germany | ||||
Int J Clin Pharmacol Ther. 2009 Oct;47(10):617-26. |
||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2009 | English | , Retrospective database analysis | |
How does The Health Improvement Network (THIN) data on prevalences on chronic diseases compare with national figures? | ||||
Blak BT & Thompson M | ||||
Cegedim | ||||
12th Annual European Congress (ISPOR) Paris, France Value in Health 12(7):A253 |
||||
, Abstract, Article, Poster | ||||
, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)74240-6/abstract | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Miscellaneous | 2009 | English | , Retrospective database analysis | |